18Feb 2017

COMPARISON OF EARLY RESULTS BETWEEN ON-PUMP AND OFF-PUMP CABG IN PATIENTS WITH PREOPERATIVE MILD TO MODERATE RENAL IMPAIRMENT.

  • M.D. Cardiothoracic surgery, National Heart Institute, Egypt
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: to compare the early results of isolated CABG, using on-pump and off-pump, in patients with preoperative mild to moderate elevation of serum creatinine (1.6 to 2.5 mg/dl) level whom do not require maintenance dialysis to support renal function. Methods: This prospective non-randomized study included 60 patients who complained of symptoms of Coronary Artery Disease and subsequently underwent myocardial revascularization at National Heart Institute of Egypt, from July 2013 till May 2014. Results: no statistically significant difference between the two groups except for: • The Hemoglobin, which is lower in on-pump group due to hemodilution effect of CPB • The troponin, as we discussed before, the 6 patients who had recent infarction we preferred to do them on-pump. • Kidney function tests Conclusions: In general, there is no single accurate investigation that can surely predict renal function outcome after cardiac surgery. •?General Measures to prevent renal dysfunction after Cardiac Surgery should be utilized in all patients with special attention to those with preoperative renal dysfunction. •?Regarding postoperative renal dysfunction and need for dialysis, results were in favor of the off-pump technique.

  1. Pitsis A, Mezilis N, Dardas P, Tsikaderis D, et al. Coronary Artery Bypass Grafting for Multi-Vessel Coronary Disease on the Beating Heart: Comparative Study of 500 Patients. Hellenic J cardiol 2002; 43: 26-31.
  2. Ascione R, Lloyd CT, Gomes WJ, Caputo M, et al. Coronary revascularisation with or without cardiopulmonary bypass: evaluation of myocardial function in a prospective randomised study. Eur J Cardiothorac Surg 1999; 15: 685-690.
  3. Zanardo G, Michieon P, Paccagnella A, Rosi P, et al. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994; 107: 1489-1495.
  4. Hayashida N, Teshima H, Chihara S, Tomoeda H, et al. Does off pump coronary artery bypass grafting really preserve renal function? Circ J 2002; 66: 921-925
  5. Boldt J, Berner T, Lehmann A, Suttner S, et al. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 2003; 75: 906-912.
  6. Sheinbaum R, Ignacio C, Safi H, Estera A. Contemporary strategies to preserve renal function during cardiac and vascular surgery. Rev Cardiovasc Med 2003; 4: S21-S28
  7. Byers J and Sladen R. Renal function and dysfunction. Curr Opin Anaesthesiol 2001; 14: 699-706.
  8. Simmons P and Anderson R. Increased serum creatinine: A marker for adverse outcome before and after cardiac surgery. Crit Care Med 2002; 30: 1664-1665.
  9. Durmaz I, Yagdi T, Calkavur T, Mahmudov R, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 2003; 75: 859-864.
  10. Lema G, Caessa R, Urzua J. Renal preservation in cardiac surgery. Curr Opin Anaesthesiol 1998; 11: 9-13.
  11. Koutlas T, Elbeery J, Williams M, Moran J, et al. Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery. Ann Thorac Surg 2000; 69: 1042-7.
  12. Alserius T, Anderson RE, Hammar N, Nordqvist T, Ivert T. Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery. Scand Cardiovasc J. 2008 Dec;42(6):392-8.
  13. Khati NJ, Hill MC, Kimmel PL. The role of ultrasound in renal insufficiency: the essentials. Ultrasound Q. 2005 Dec; 21(4): 227-44.
  14. Loef BG, Epema AH, Navis G, Ebels T, van Oeveren W, Henning RH. Off pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. 2002 Apr;121(4):1190-4.
  15. Pramodh K, Vani, Muralidhar K: Renal function following CABG: Onpump vs off pump Ind J Thorac Cardiovasc Surg, 2003;19: 169–173.
  16. Wehlin L, Vedin J, Vaage J, Lundahl J Activation of complement and leukocyte receptors during on and off pump coronary artery bypass surgery European Journal of Cardio-thoracic Surgery 2004;25:35-42.
  17. Limacher MC (1996) Coronary heart disease in women. Past gaps, present state and future promises. J Fla Med Assoc 1996; 83: 455-458.
  18. Kaiser, Larry R.; Kron, Irving L.; Spray, Thomas L. Title: Mastery of Cardiothoracic Surgery, 2nd Edition Lippincott Williams & Wilkins
  19. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA; American College of Cardiology; American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). 2004 Oct 5;110(14):e340- 437.
  20. Thakar CV, Arrigain S, Worley S, Yared J-P, Paganini EP: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005;16: 162–168
  21. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006; 1:19.
  22. Lazar HL: The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery. Vascul Pharmacol 2005; 42: 119–123.
  23. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low- Osmolar Non-Ionic Contrast Media Study Investigators: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–499.
  24. Jarnberg PO: Renal protection strategies in the perioperative period. Best Pract Res Clin Anaesthesiol 2004; 18: 645–660.
  25. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
  26. Cooper JR, Giesecke NM: Hemodilution and priming solutions. In: Cardiopulmonary Bypass: Principles and Practice, edited by Gravlee GP, Davis RF, Kurusz M, Utley JR, Philadelphia, Lippincott Williams & Wilkins, 2000, pp 186–196.
  27. Rigden SP, Dillon MJ, Kind PR, de Leval M, Stark J, Barratt TM: The beneficial effect of mannitol on postoperative renal function in children undergoing cardiopulmonary bypass surgery. Clin Nephrol 1984; 21: 148–151.
  28. Fisher AR, Jones P, Barlow P, Kennington S, Saville S, Farrimond J, Yacoub M: The influence of mannitol on renal function during and after open-heart surgery. Perfusion 1998; 13:181–186.
  29. Carcoana OV, Mathew JP, Davis E, Byrne DW, Hayslett JP, Hines RL,Garwood S: Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg 2003; 97: 1222–1229.
  30. Sirivella S, Gielchinsky I, Parsonnet V: Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000; 69: 501– 506.
  31. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232–244.
  32. Cagli K, Ulas MM, Ozisik K, Kale A, Bakuy V, Emir M, Balci M, Topbas M, Sener E, Tasdemir O: The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 2005; 20: 45–51.
  33. Zhang M, Xu YJ, Saini HK, Turan B, Liu PP, Dhalla NS: Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in the ischemic-reperfused heart. Am J Physiol Heart Circ Physiol. 2005; 289: 832–839.
  34. Boldt J, Brosch C, Piper SN, Suttner S, Lehmann A, Werling C: Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 2001; 29: 952–958.
  35. Shernan SK, Fitch JC, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT; Pexelizumab Study Investigators: Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. Ann Thorac Surg 2004;
  36. 77: 942–949.
  37. Sucu N, Cinel I, Unlu A, Aytacoglu B, Tamer L, Kocak Z, Karaca K, Gul A, Dikmengil M, Atik U, Oral U: N-acetylcysteine for preventing pumpinduced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 2004; 34: 237–242.
  38. Kshirsagar AV, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Magnus Ohman E, Finn WF: Nacetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004; 15: 761–769.
  39. Myles PS, Hunt JO, Holdgaard HO, McRae R, Buckland MR, Moloney J, Hall J, Bujor MA, Esmore DS, Davis BB, Morgan DJ: Clonidine and cardiac surgery: Haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care 1999; 27: 137–147.
  40. Kulka PJ, Tryba M, Zenz M: Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial. Crit Care Med 1996; 24: 947–952.
  41. Fansa I, Gol M, Nisanoglu V, Yavas S, Iscan Z, Tasdemir O: Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass? Med Sci Monit 2003; 9: I30–I36.
  42. Bergman AS, Odar-Cederlof I, Westman L, Bjellerup P, Hoglund P,Ohqvist G: Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction. J Cardiothorac Vasc Anesth 2002; 16: 294–299.
  43. Piper SN, Kumle B, Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth 2003;50:285- 292.

[Ali Emad Ashraf Abdel Aziz, Tamer Elbanna, Mostafa Mansy and Amr Alprince. (2017); COMPARISON OF EARLY RESULTS BETWEEN ON-PUMP AND OFF-PUMP CABG IN PATIENTS WITH PREOPERATIVE MILD TO MODERATE RENAL IMPAIRMENT. Int. J. of Adv. Res. 5 (Feb). 694-707] (ISSN 2320-5407). www.journalijar.com

Mostafa Mansy
MD cardio-thoracic Surgeon

DOI:

Article DOI: 10.21474/IJAR01/3204      
DOI URL: http://dx.doi.org/10.21474/IJAR01/3204

Download Full Paper

Download PDF No. of Downloads: 10 | No. of Views: 67